Napa Wealth Management Trims Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Napa Wealth Management reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 52.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,951 shares of the healthcare conglomerate's stock after selling 2,141 shares during the period. Napa Wealth Management's holdings in UnitedHealth Group were worth $987,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in UNH. Geode Capital Management LLC increased its stake in shares of UnitedHealth Group by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after acquiring an additional 319,515 shares in the last quarter. Capital International Investors grew its stake in shares of UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after buying an additional 906,365 shares during the last quarter. Norges Bank purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth $6,375,744,000. Northern Trust Corp increased its stake in UnitedHealth Group by 12.5% during the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after purchasing an additional 1,058,488 shares in the last quarter. Finally, Franklin Resources Inc. lifted its position in UnitedHealth Group by 10.7% in the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after acquiring an additional 861,854 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have commented on UNH. Truist Financial cut their target price on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a research report on Monday, April 21st. Robert W. Baird cut their price objective on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating for the company in a research report on Wednesday. KeyCorp reduced their target price on shares of UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating on the stock in a report on Wednesday. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Finally, Mizuho lifted their target price on UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Six equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $508.38.

UnitedHealth Group Trading Down 11.1%

Shares of UnitedHealth Group stock traded down $34.05 on Thursday, hitting $273.96. 121,312,755 shares of the company traded hands, compared to its average volume of 5,582,486. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock's 50 day moving average price is $478.83 and its 200-day moving average price is $517.83. The company has a market cap of $248.52 billion, a PE ratio of 17.67, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 52 week low of $249.12 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period last year, the business posted $6.91 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 3.07%. UnitedHealth Group's dividend payout ratio is presently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.